Dr Enid Lam
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
62 Scholarly works
5 Projects
HIGHLIGHTS
2026
Journal article
DOT1L provides transcriptional memory through PRC1.1 antagonism
DOI: 10.1038/s41556-025-01859-82022
Journal article
Non-genetic determinants of malignant clonal fitness at single-cell resolution
DOI: 10.1038/s41586-021-04206-72022
Conference Proceedings
SUMOYLATION OF DNMT1 REGULATES RESPONSE TO CATALYTIC INHIBITION OF DNMT1 IN ACUTE MYELOID LEUKAEMIA
DOI: 10.1016/j.exphem.2022.07.1782022
Research grants (ARC, NHMRC, MRFF)
Understanding and Averting Blood Cancer Resistance to Therapy
2020
Research Grant
Understanding Genetic and Non-Genetic Resistance to Therapeutic Pressure in Acute Myeloid Leukaemia
2020
Research Grant
Exploiting RNA Export as a Novel Treatment Strategy for Cancer
2019
Journal article
Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
DOI: 10.1038/s41591-018-0243-z
RECENT SCHOLARLY WORKS
2026
Journal article
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors
DOI: 10.1038/s41590-025-02347-92025
Other
Figure S5 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
DOI: 10.1158/2159-8290.308696182025
Other
Figure S7 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
DOI: 10.1158/2159-8290.308696122025
Other
Table S2 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
DOI: 10.1158/2159-8290.308696062025
Other
Figure S3 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
DOI: 10.1158/2159-8290.308696242025
Other
Table S1 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
DOI: 10.1158/2159-8290.308696092025
Other
Figure S6 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
DOI: 10.1158/2159-8290.308696152025
Other
Figure S2 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
DOI: 10.1158/2159-8290.30869627